{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:47:36Z","timestamp":1771552056281,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC2002000"],"award-info":[{"award-number":["2018YFC2002000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bbrc.2023.05.038","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T12:55:40Z","timestamp":1684155340000},"page":"50-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["TLR2 and CASP7 as the biomarkers associated with non-alcoholic fatty liver disease and chronic kidney disease"],"prefix":"10.1016","volume":"667","author":[{"given":"Ziwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengpei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrc.2023.05.038_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bbrc.2023.05.038_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J.\u00a0Hepatol."},{"issue":"5","key":"10.1016\/j.bbrc.2023.05.038_bib3","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"issue":"10290","key":"10.1016\/j.bbrc.2023.05.038_bib4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.bbrc.2023.05.038_bib5","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.bbrc.2023.05.038_bib6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Kidney Disease: improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M: evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.bbrc.2023.05.038_bib7","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/S2214-109X(16)00071-1","article-title":"Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study","volume":"4","author":"Ene-Iordache","year":"2016","journal-title":"Lancet Global Health"},{"issue":"10159","key":"10.1016\/j.bbrc.2023.05.038_bib8","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bbrc.2023.05.038_bib9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2010.07.022","article-title":"Nonalcoholic steatohepatitis and increased risk of chronic kidney disease","volume":"60","author":"Yasui","year":"2011","journal-title":"Metab., Clin. Exp."},{"issue":"5","key":"10.1016\/j.bbrc.2023.05.038_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.bbrc.2023.05.038_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J.\u00a0Hepatol."},{"issue":"6","key":"10.1016\/j.bbrc.2023.05.038_bib12","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bbrc.2023.05.038_bib13","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbrc.2023.05.038_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12920-022-01300-1","article-title":"Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation","volume":"15","author":"Chu","year":"2022","journal-title":"BMC Med. Genom."},{"issue":"5","key":"10.1016\/j.bbrc.2023.05.038_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.bbrc.2023.05.038_bib16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2014","journal-title":"Am. J. Kidney Dis."},{"issue":"3\u20134","key":"10.1016\/j.bbrc.2023.05.038_bib17","first-page":"399","article-title":"Differential membrane expression of Toll-like receptors and intracellular cytokine induction in peripheral blood monocytes of patients with chronic kidney disease and diabetic nephropathy","volume":"128","author":"Zikou","year":"2014","journal-title":"Nephron Clin. Pract."},{"issue":"2","key":"10.1016\/j.bbrc.2023.05.038_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.26081","article-title":"Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice","volume":"57","author":"Miura","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2023.05.038_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106368","article-title":"Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-kappaB pathways","volume":"82","author":"Wu","year":"2020","journal-title":"Int. Immunopharm."},{"issue":"11","key":"10.1016\/j.bbrc.2023.05.038_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114189","article-title":"Relationship between IL-8 circulating levels and TLR2 hepatic expression in women with morbid obesity and nonalcoholic steatohepatitis","volume":"21","author":"Auguet","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbrc.2023.05.038_bib21","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/ndt\/gfq500","article-title":"Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation","volume":"26","author":"Koc","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.bbrc.2023.05.038_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/labinvest.2009.123","article-title":"Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-choline-deficient diet","volume":"90","author":"Mu","year":"2010","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.bbrc.2023.05.038_bib23","article-title":"Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease","volume":"37","author":"Cimini","year":"2021","journal-title":"Diabetes\/Metabol. Res. Rev."},{"issue":"4","key":"10.1016\/j.bbrc.2023.05.038_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000104741","article-title":"Caspase-7, Fas and FasL in long-term renal ischaemia\/reperfusion and immunosuppressive injuries in rats","volume":"27","author":"Yang","year":"2007","journal-title":"Am. J. Nephrol."},{"issue":"5","key":"10.1016\/j.bbrc.2023.05.038_bib25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.kint.2017.06.030","article-title":"AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms","volume":"92","author":"He","year":"2017","journal-title":"Kidney Int."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23006010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23006010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:29:35Z","timestamp":1757766575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23006010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":25,"alternative-id":["S0006291X23006010"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.05.038","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR2 and CASP7 as the biomarkers associated with non-alcoholic fatty liver disease and chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}